News & Views | Published:

Reprogramming the diseased brain

Nature Biotechnology volume 35, pages 426428 (2017) | Download Citation

Direct conversion of astrocytes to dopamine neurons in vivo offers fresh optimism for the development of improved Parkinson's disease therapies.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Nat. Biotechnol. 35, 444–452 (2017).

  2. 2.

    et al. Science 247, 574–577 (1990).

  3. 3.

    et al. Cell Stem Cell 15, 653–665 (2014).

  4. 4.

    et al. Stem Cell Rep. 2, 337–350 (2014).

  5. 5.

    et al. Cell 167, 566–580.e19 (2016).

  6. 6.

    et al. Nature 476, 224–227 (2011).

  7. 7.

    et al. Cell Res. 22, 321–332 (2012).

  8. 8.

    , & Development 143, 2494–2510 (2016).

  9. 9.

    et al. Sci. Rep. 3, 2157 (2013).

  10. 10.

    et al. Mol. Ther. 19, 1048–1057 (2011).

  11. 11.

    , & Hum. Gene Ther. 27, 522–527 (2016).

Download references

Author information

Affiliations

  1. Stephen B. Dunnett and Anne E. Rosser are in The Brain Repair Group, Cardiff University School of Biosciences, Cardiff, Wales, UK.

    • Stephen B Dunnett
    •  & Anne E Rosser

Authors

  1. Search for Stephen B Dunnett in:

  2. Search for Anne E Rosser in:

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Stephen B Dunnett or Anne E Rosser.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.3869

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing